Buy Hepion Pharmaceuticals Inc Stock | HEPA Stock Price & Latest News | Public.com
HEPA

Hepion Pharmaceuticals Inc

$0.00 (0.00%)Today
    Small Market Cap
    View Hepion Pharmaceuticals Inc (HEPA) stock trends here

    About HEPA

    Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.23
    -0.46
    -0.69
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.20

    Actual EPS
    Q1 2021

    Stats

    Market Cap$141,77M
    Volume3,45M
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.83
    1 Year Low$1.00
    Open$1.88
    High$1.89
    Low$1.64

    Buy any stock with any amount of money.

    Download the App
    Download the app